[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 5, Issue 1 (3-2003) ::
2003, 5(1): 27-32 Back to browse issues page
Lipids, apolipoproteins, lipid oxidation and paraoxonase enzyme activity in diabetic and non-diabetic end stage renal disease patients
M Solati , A Etemadi , P Pezeshk , KH Rahbar , F Azizi
, solati@erc-iran.com
Abstract:   (31419 Views)
Introduction: Paraoxonase (an HDL-associated enzyme) is believed to protect lipoproteins against peroxidation. Patients with end stage renal failure on hemodialysis are exposed to oxidative stress. In this study we investigated the status of paraoxonase activity, TAC and oxidized LDL in a population of diabetic and non-diabetic ESRD patients. Material and Methods: The study population consisted of 46 patients with diabetes and 46 non diabetics and 46 control participants. Patients were selected from hemodialysis centers of Shaheed Beheshti University of Medical Sciences. Individuals with thyroid dysfunction, Cerebrovascular accident, recent coronary event, recent hospitalization or under treatment with lipid-lowering agents were excluded. A fasting predialysis sample was obtained. Paraoxonase activity was measured by spectrophotometer, measuring P-nitrophenol paraoxon after adding paraoxon to the sera and TAC by adding 20µL serum to PBS (80µmol/L, PH=7.4) and 6.1 µmol/L metmyoglobin and ABTS (as a chromogen and substrate) and hydrogen peroxide as a substrate. The decrease in blue-green color was measured by Elisa reader. Results: 46 diabetic patients, 26 men and 20 women, aged 61.8±10 and 46 non diabetic ESRD patients, 25 men and 21 women, aged 61.5±9.9, and 46 healthy controls, 24 men and 22 women, aged 60.8±10.0 were studied. Significant reduction in serum paraoxonase activity in non diabetic ESRD and diabetic patients compared with control group was present (47.2±32.2 VS 9.5±48.6 VS 86.4±62.5 IU/mL, respectively). While these groups showed no significant change in oxidized LDL and TAC. Paraoxonase activity was significantly lower in non diabetic ESRD patients than diabetics. Conclusion: It has been shown that there is enhanced oxidative stress in patients with diabetes mellitus and chronic renal failure. Reduction in paraoxonase activity may have a role in this process.
Keywords: Paraoxonase, Diabetes mellitus, Chronic renal failure, Lipid oxidation, Antioxidants
Full-Text [PDF 315 kb]   (6080 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2006/11/23 | Published: 2003/03/15
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Solati M, Etemadi A, Pezeshk P, Rahbar K, Azizi F. Lipids, apolipoproteins, lipid oxidation and paraoxonase enzyme activity in diabetic and non-diabetic end stage renal disease patients. Iranian Journal of Endocrinology and Metabolism 2003; 5 (1) :27-32
URL: http://ijem.sbmu.ac.ir/article-1-228-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 5, Issue 1 (3-2003) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4645